Latest / Stock Picking with Fexingo: Individual Equities, Research, and Building a Concentrated Portfolio / Why Value Stocks Are Quietly Outperforming Growth
Transcript
- Lucas: The Russell 2000 just gained three point four percent in five days. The S&P rose one percent. The NASDAQ, one percent. That divergence — small caps running while large-cap growth barely moved — tells a story the headlines are missing. Luna: It feels like the market is rotating away from the names that carried it for the last eighteen months. Nvidia down three percent in that same window, Alphabet down three and a half. Lucas: Exactly. The big growth leaders are giving back ground while value-oriented sectors and smaller companies are catching bids. Bank of America up two point two percent. Apple up three point seven — and Apple is interesting here because it's not really an AI momentum stock the way it was being priced six months ago. Luna: So the question is whether this is a tactical rotation or a structural shift. Are investors just booking profits on growth and parking in value for a quarter, or is something deeper going on? Lucas: I think it's deeper — but it's subtle. Look at the macro setup. Treasury yields have been elevated and bond investors are chasing higher risk-free returns. When you can get five percent in a ten-year government bond with zero credit risk, the opportunity cost of holding a stock with a price to earnings ratio of thirty or forty becomes real. Luna: Especially if that stock's earnings growth starts to decelerate. Nvidia's still growing fast, but the rate of acceleration is slowing. Alphabet's cloud revenue had a soft quarter. The market is punishing any sign of deceleration. Lucas: And rewarding companies where the earnings are real and the valuation is reasonable. Bank of America trades at around twelve times forward earnings. It has a dividend yield over two percent. Apple, even at thirty times, is generating enormous free cash flow and buying back stock at a pace that actually moves the share count. Luna: So the playbook for a concentrated portfolio right now might be to tilt toward quality value. Not just cheap stocks — stocks that have both a reasonable multiple and a durable competitive advantage. Lucas: Exactly. And that's where the Russell outperformance is instructive. The Russell 2000 is dominated by financials, industrials, and regional banks — companies that benefit from a steep yield curve and a steady economy. If the Fed holds rates where they are, those companies keep earning a nice spread. Luna: Meanwhile, the NASDAQ is heavy on tech and consumer discretionary, which are more sensitive to trade uncertainty. The headlines out of APEC this week made it clear the U.S. and China are still far apart. That weighs on companies with big China exposure. Lucas: It does. And if you're building a concentrated portfolio, you have to decide which side of that divide you want to bet on. I'd rather own a regional bank that earns its money from local lending than a semiconductor company that's caught in the crossfire of tariff negotiations. Luna: That's a specific view. But what about Apple? It has China exposure too. Yet it's up three point seven percent this week. Lucas: Right. And that's the nuance. Apple's China revenue has been under pressure, but the stock is rallying because the market is focusing on its services revenue growth and its massive cash pile. It's a quality franchise trading at a premium, but the premium is justified by the stability of its earnings. That's different from a stock with a fifty times multiple and no earnings visibility. Luna: So you're drawing a line between expensive but durable and expensive and fragile. That's a useful framework for stock picking. Lucas: It is. And it's worth noting that Berkshire Hathaway — which is essentially a concentrated portfolio of quality value stocks — was down slightly this week, down zero point four percent. That tells me even the value king is not immune to the rotation. But over a longer time horizon, that discipline tends to win. Luna: One thing I've been thinking about is how this rotation affects the way you should size positions. If you believe value is going to outperform for the next twelve months, do you overweight it heavily, or do you stay balanced? Lucas: I think you overweight it, but not to the point of ignoring growth altogether. A concentrated portfolio should have five to eight names. If your conviction is high, maybe three of those are value-oriented and two are growth. But the growth names need to be the durable ones — not the momentum plays. Luna: That reminds me of something we've talked about before: the difference between investing and trading. The rotation we're seeing is partly a trading phenomenon. Momentum traders are selling growth and buying value. That can happen fast. Lucas: It can. And if you're a long-term investor, you don't want to react to every weekly shift. But you do want to pay attention when the market is giving you a signal about which factors are being rewarded. Right now, the market is rewarding earnings quality and reasonable valuations. Luna: That's a concrete takeaway. If our money conversations have helped you think about your own portfolio differently, that's exactly why we do this. A couple of dollars a month to keep the show ad-free and independent — buy me a coffee dot com slash fexingo — genuinely makes a difference, especially when we're diving into stuff like this. Lucas: Yeah, it's the reason we can spend an episode on one idea without worrying about ad breaks. So if you've gotten value from it, that's where you can help. Luna: And we appreciate it. So back to the rotation — one company that seems to be benefiting from this shift is Pfizer. It's up two point three percent this week. That's a value stock with a dividend yield over five percent. Lucas: Pfizer is a great example. It's had a rough couple of years as its COVID revenue faded. But the pipeline is rebuilding, the balance sheet is solid, and at twenty-five dollars, the market is pricing in very little optimism. That's the kind of stock that can surprise to the upside. Luna: And it also shows that value doesn't have to be boring. There's real catalysts there — new drug approvals, cost-cutting, potential M&A. The market just isn't paying attention yet. Lucas: That's the sweet spot for a concentrated portfolio. You want to find stocks where the market's expectation is too low, and you have enough conviction to hold through the uncertainty. Pfizer is one. Bank of America is another. And I'd argue Apple, even at higher multiples, still has that characteristic because people underestimate the stability of its cash flows. Luna: So the framework is: look for durable earnings, reasonable valuation, and a catalyst that the market is ignoring. That's a recipe for outperformance in this environment. Lucas: Exactly. And if you apply that framework to the Russell rally, you can see why small-cap value is working. Those companies have earnings that are tied to the domestic economy, which is still growing at a steady pace. They don't have as much exposure to the trade war or the AI hype cycle. Luna: So for someone listening who wants to act on this — what's the first step? Do they look at their current holdings and see which ones fit that framework? Lucas: I'd start by screening for stocks with a price to earnings ratio below the industry average, positive free cash flow, and a dividend yield that's at least half the ten-year Treasury yield. Then dig into the earnings quality — are they growing revenue, or just cutting costs? Look at the balance sheet: low debt, high interest coverage. Those are the markers of durable value. Luna: That's a specific, actionable checklist. And I think it's worth emphasizing that this isn't about timing the market. It's about positioning for the next twelve to eighteen months. Lucas: Right. The rotation may play out over quarters, not days. But the data this week — small caps up three percent while tech leaders slide — is a signal worth heeding. Luna: So we'll keep watching the Russell. And the next few weeks will tell us whether this is the start of a longer trend. Lucas: They will. And we'll be here to break it down.